As was depicted in Figure 1A, SOX13 was expressed remarkably higher in cholangiocarcinoma (CHOL), breast invasive carcinoma (BRCA), esophageal carcinoma (ESCA), etc. compared to normal tissues. This evidence concerns the gene SOX13 and invasive breast carcinoma.